drugset / Trial / NCT01132612
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to provide long term clinical data for the compound for the treatment of the indication of moderate to severe chronic plaque-type psoriasis.
Timeline
- Start
- 2010-05-11
- Primary completion
- 2016-10-18
- Completion
- 2016-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Secukinumab | Monoclonal antibody | 150 mg | — |